Moderna shares fall despite promising data from cancer vaccine trial
Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.
Source link
- Alphabet shares dip on report Samsung phones may switch to Microsoft Bing search
- Chinese engineer charged with blasphemy in Pakistan
